Articles published by Gain Therapeutics, Inc.
Via GlobeNewswire
Tickers
GANX
Via GlobeNewswire
Tickers
GANX
Via GlobeNewswire
Tickers
GANX
Via GlobeNewswire
Tickers
GANX
Gain Therapeutics Reports Financial Results for Year End 2023 and Provides Corporate Update
March 26, 2024
Via GlobeNewswire
Tickers
GANX
Via GlobeNewswire
Tickers
GANX
Gain Therapeutics Announces 2024 R&D Update on Parkinson’s Disease with KOL & Analyst Insight
February 14, 2024
Via GlobeNewswire
Tickers
GANX
UPDATE - Gain Therapeutics’ GT-02287 Completely Restores Motor Function in Mouse Models of Parkinson’s Disease
February 06, 2024
Via GlobeNewswire
Tickers
GANX
Gain Therapeutics’ GT-02287 Completely Restores Motor Function in Mouse Models of Parkinson’s Disease
February 06, 2024
Via GlobeNewswire
Tickers
GANX
Gain Therapeutics’ CEO Matthias Alder Issues Letter to Shareholders and Provides Operational Update
January 31, 2024
Via GlobeNewswire
Tickers
GANX
Gain Therapeutics to Participate in FORCE Family Office Event with Zacks Small-Cap Research
December 04, 2023
Via GlobeNewswire
Tickers
GANX
Gain Therapeutics to Participate in AI Driven Drug Discovery Summit
November 29, 2023
Via GlobeNewswire
Tickers
GANX
Gain Therapeutics Announces Proposed Public Offering
November 20, 2023
Via GlobeNewswire
Tickers
GANX
Gain Therapeutics Announces Third Quarter 2023 Financial Results and Business Update
November 14, 2023
Via GlobeNewswire
Tickers
GANX
Gain Therapeutics to Participate at Cantor Fitzgerald Global Healthcare Conference 2023
September 25, 2023
Via GlobeNewswire
Tickers
GANX
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.